These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9342486)

  • 1. Nephelometry in the clinical assessment of glomerular proteinuria and tubular function in diabetic nephropathy.
    Solerte SB; Severgnini S; Locatelli M; Cerutti N; Rondanelli M; Netti MA; Ferrari E; Fioravanti M
    Clin Nephrol; 1997 Sep; 48(3):151-8. PubMed ID: 9342486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal function in adult Nigerian diabetics.
    Arije A; Akinsola W; Ladipo GO
    Trop Geogr Med; 1988 Oct; 40(4):334-7. PubMed ID: 3227554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced urinary adiponectin excretion in IgA-nephropathy patients with proteinuria.
    Shimotomai T; Kakei M; Narita T; Koshimura J; Hosoba M; Kato M; Komatsuda A; Ito S
    Ren Fail; 2005; 27(3):323-8. PubMed ID: 15957550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
    Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy].
    Yashima I; Hirayama T; Shiiki H; Kanauchi M; Dohi K
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):787-96. PubMed ID: 10655727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.
    Guerrero-Romero F; Rodríguez-Morán M; Paniagua-Sierra JR; García-Bulnes G; Salas-Ramírez M; Amato D
    Clin Nephrol; 1995 Feb; 43(2):116-21. PubMed ID: 7736673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of proteinuria as a marker of nephropathy in type 2 diabetes mellitus.
    Aryal M; Jha B
    Nepal Med Coll J; 2006 Dec; 8(4):250-3. PubMed ID: 17357643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microalbuminuria: theoretical bases and new applications].
    Airoldi G; Campanini M
    Recenti Prog Med; 1993 Mar; 84(3):210-24. PubMed ID: 8465103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinuria in children with sickle cell disease.
    Marsenic O; Couloures KG; Wiley JM
    Nephrol Dial Transplant; 2008 Feb; 23(2):715-20. PubMed ID: 18065783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic significance of urinary transferrin in diabetic nephropathy.
    Kanauchi M; Nishioka H; Hashimoto T; Dohi K
    Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):649-54. PubMed ID: 8583702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early indicators of diabetic nephropathy. Changes in selective proteinuria].
    Cristina G; De Matteis GM
    Recenti Prog Med; 1994 Nov; 85(11):540-5. PubMed ID: 7855388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary excretion and renal clearance of several specific plasma proteins in diabetics].
    Khristov V; Popova D; Kolebinov N
    Vutr Boles; 1987; 26(3):64-8. PubMed ID: 3617708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy.
    Koshimura J; Fujita H; Narita T; Shimotomai T; Hosoba M; Yoshioka N; Kakei M; Fujishima H; Ito S
    Biochem Biophys Res Commun; 2004 Mar; 316(1):165-9. PubMed ID: 15003525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albuminuria estimated from proteinuria in diabetics. Is it a real alternative in clinical practice?
    Giampietro O; Clerico A; Miccoli R; Cruschelli L; Di Palma L; Navalesi R
    Diabetes Res; 1988 May; 8(1):39-43. PubMed ID: 3224494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.